383 related articles for article (PubMed ID: 9425690)
1. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
[TBL] [Abstract][Full Text] [Related]
2. Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent.
Jaber SH; Cowen EW; Haworth LR; Booher SL; Berman DM; Rosenberg SA; Hwang ST
Arch Dermatol; 2006 Feb; 142(2):166-72. PubMed ID: 16490844
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous disease and drug reactions in HIV infection.
Coopman SA; Johnson RA; Platt R; Stern RS
N Engl J Med; 1993 Jun; 328(23):1670-4. PubMed ID: 8487826
[TBL] [Abstract][Full Text] [Related]
4. T cell populations propagating in the peripheral blood of patients with drug eruptions.
Nishio D; Izu K; Kabashima K; Tokura Y
J Dermatol Sci; 2007 Oct; 48(1):25-33. PubMed ID: 17601705
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts.
Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI
Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796
[TBL] [Abstract][Full Text] [Related]
6. Sexually transmitted diseases in 1161 HIV-positive patients: a 38-month prospective study in southern Spain.
Muñoz-Pérez MA; Rodriguez-Pichardo A; Camacho Martinez F
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):221-6. PubMed ID: 9883433
[TBL] [Abstract][Full Text] [Related]
7. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption.
Kano Y; Hirahara K; Mitsuyama Y; Takahashi R; Shiohara T
Allergy; 2007 Dec; 62(12):1439-44. PubMed ID: 17983378
[TBL] [Abstract][Full Text] [Related]
8. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K
East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of cutaneous drug reactions.
Puavilai S; Timpatanapong P
J Med Assoc Thai; 1989 Mar; 72(3):167-71. PubMed ID: 2525591
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of cutaneous drug eruptions by STI571.
Park HJ; Kim HS; Kim HJ; Lee JY; Cho BK; Lee AW; Yoon DY; Cho DH
J Dermatol Sci; 2005 Apr; 38(1):9-15. PubMed ID: 15795119
[TBL] [Abstract][Full Text] [Related]
11. HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4⁺ T cells.
Yang C; Mosam A; Mankahla A; Dlova N; Saavedra A
J Am Acad Dermatol; 2014 Jun; 70(6):1096-102. PubMed ID: 24629995
[TBL] [Abstract][Full Text] [Related]
12. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
13. T cell-mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests.
Kanny G; Pichler W; Morisset M; Franck P; Marie B; Kohler C; Renaudin JM; Beaudouin E; Laudy JS; Moneret-Vautrin DA
J Allergy Clin Immunol; 2005 Jan; 115(1):179-85. PubMed ID: 15637566
[TBL] [Abstract][Full Text] [Related]
14. Allergic cutaneous reactions to drugs.
Bigby M; Stern RS; Arndt KA
Prim Care; 1989 Sep; 16(3):713-27. PubMed ID: 2529577
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic features seen in cutaneous photoeruptions in HIV-positive patients. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
Smith KJ; Skelton HG; Yeager J; Tuur S; Angritt P; Wagner KF
Int J Dermatol; 1997 Oct; 36(10):745-53. PubMed ID: 9372348
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of cutaneous drug eruptions in adult Nigerians with HIV/AIDS.
Salami TA; Asalu AF; Samuel SO
Niger Postgrad Med J; 2010 Jun; 17(2):160-3. PubMed ID: 20539333
[TBL] [Abstract][Full Text] [Related]
17. In vitro interleukin-5 (IL-5) production by peripheral blood mononuclear cells from patients with drug hypersensitivity.
Mikami C; Ochiai K; Kagami M; Tomioka H; Tanabe E
J Dermatol; 1996 Jun; 23(6):379-81. PubMed ID: 8708148
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate.
Scheinfeld N
J Drugs Dermatol; 2006 Mar; 5(3):228-31. PubMed ID: 16573254
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous drug reactions associated with newer antiretroviral agents.
Martins CR
J Drugs Dermatol; 2006; 5(10):976-82. PubMed ID: 17373147
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
